Summary Data collected from lung cancer patients attending the Victoria Clinic of the British Columbia Cancer Agency are used to investigate how resources are rationed in the treatment of non-small-cell lung cancer (NSCLC). An al., 1981; Aaron and Schwartz, 1984; Goodwin et al., 1987; Greenberg et al., 1988; Naylor et al., 1993) .
In a government-funded public health care system, such as the Canadian model, the matching of limited resources to health care needs can be viewed as a two-tiered process of allocation and rationing (Evans, 1983a,b) . Allocation is the distribution of resources according to a predetermined plan at the aggregate, or health care programme, level. Allocation decisions are typically made by government officials on the basis of information provided largely by health care programme administrators and analysts. Patients and their families provide at best only minimal direct input into allocation decisions. The term rationing is used by Evans (1983a,b) non-pejoratively to refer to how programme allocations are apportioned at the individual patient level. Rationing decisions are made jointly by the care providers, the patient and the patient's family and may be based on good clinical practice and appropriate use of resources and interventions. These decisions will reflect any explicit guidelines for the use of programme funds, as well as the care provider and patient's personal assessments of the need for care and of the potential net benefits of treatment. The nature and appropriateness of the criteria governing allocation and rationing in the health care sector are the focus of an expanding literature (Detsky et al., 1981; Aaron and Schwartz, 1984; Goodwin et al., 1987; Greenberg et al., 1988; Naylor et al., 1993) .
Although some of the criteria governing rationing may be explicitly formulated by programme administrators, additional criteria come into play implicitly as care providers and patients and their families interpret and react to the formal guidelines. Thus, for a full understanding and appreciation of resource rationing in the treatment of a specific condition, all the rationing criteria need to be identified and their relevance assessed. Our paper contributes to this process for non-smallcell lung cancer (NSCLC) by identifying the rationing criteria implicit in the primary treatment decisions for NSCLC at the Victoria clinic (ViCC) of the British Columbia Cancer Agency (BCCA). Moreover, it does so by using a more general model of the rationing decision and a larger set of potential rationing criteria than used thus far.
To date, rationing is usually modelled as a decision of whether or not a patient will receive a specified treatment. This binary decision is analysed with a logit model in which the probability that the patient will receive the specified treatment is a function of disease-specific factors, functional status and personal attributes. However, it is frequently the case, as it is with NSCLC, that a specific condition can be treated in a variety of ways. Thus, in our analysis the rationing decision is modelled as a choice from a range of discrete primary treatment options ranked from no treatment, to progressively more elaborate palliative treatment, to progressively more aggressive radical treatment. We therefore use the ordered logit, rather than the logit, regression model. Furthermore, our model not only brings together into one analysis the disease-specific and functional status variables used elsewhere to capture rationing based on medical criteria but also adds tumour size and weight loss, two variables whose impact on the treatment decision have not yet been quantified. Of special interest is whether, after this extensive adjustment for rationing on the basis of purely medical considerations, additional rationing also occurs on the basis of one or more of four non-medical variables: age, gender, marital status and smoker status.
Materials and methods Patients
The data were obtained through the cooperation of (McKelvey and Zavoina, 1975; Greene, 1990, pp. (Kennedy, 1987, p. 71 ) is used to test whether the pared down model is correctly specified. The estimation and tests were performed with LIMDEP (Greene, 1992) .
The goodness of fit of ordered logit models cannot be measured with the well-known adjusted R2. One frequently used alternative is the likelihood ratio index (LRI):
where lnL is the log of the likelihood for the estimated model and lnL0 is the log of the likelihood when all the slope parameters are set equal to zero, i.e. none 
Ordered logit regression results
The regression results for the ordered logit model using all the variables in Table I n/a n/a n/a n/a 7279.20e 7279.20 aComputerised planning beyond basic requirement. b Custom shielding employed. CSource: Coy et al. (1994) . (6) 2350 (5) 6146 (4) 2305 (3) 3860 (5) 65-74 1355 (6) 1556 (24) 1652 (9) 4728 (7) 2670 (5) 4052 (4) > 74 1056 (8) 1637 (21) 1278 (5) 2990 (5) 2758 (4) 3647 (6) aThe number of patients in the category is shown in parentheses. (Mor et al., 1985; Samet et al., 1986; Greenberg et al., 1988; Scitovsky, 1988) proportion of the group that has the specified characteristic. The simulation for each age group yields a probability distribution across the seven treatment expenditure categories (see Appendix). The expected expenditure for a given age is then computed as the weighted sum of the expenditure in each treatment category, where the weights are the simulated probabilities. Column 2 in Table V is obtained by repeating the simulation for non/ex-smokers. A similar two-step procedure is used to generate the other columns in Table V .
The columns in Table V show that the expected expenditure on lung cancer treatment declines appreciably with age. The expected treatment expenditure for an 85-yearold is about one-third the expected expenditure for a 50-yearold when both have a KPS <80. When both have a KPS > 80 the expected treatment expenditure for an 85-year-old is about one-half the expenditure for a 50-year-old. Within each KPS category the expected treatment expenditure for an active smoker is from 16% to 29% less, depending on KPS and age, than for an equivalent patient who is a non-or former smoker.
As noted earlier, the model simulations across age and smoker status within a KPS category are for the average 1928  2468  3777  4550  4628  5384  55  1685  2180  3402  4151  4229  5006   60  1465  1916  3046  3760  3836  4611  65  1264  1675  2715  3385  3457  4211  70  1083  1455  2408  3031  3099  3819  75  920  1256  2125  2701  2763  3441  80  774  1075  1866  2395  2453  3083  85  645  913  1629  2113  2166  2749 785 Columbia, 1988) . This is consistent with a growing awareness that older patients may have a biological age anywhere on a broad spectrum (Cohen, 1995) and that age, per se, is not a relevant prognostic or medical criterion for the treatment of lung cancer (Sherman and Guidot, 1987; Lipschitz, 1995 
